Table of Contents
Table 5-2: Allen
Table 5-4: Benton
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 174 | 519.5 | 815 | 501.4 | 89 | 295.5 | 382 | 252.3 |
| Esophagus | * | # | 12 | 6.7** | * | # | 7 | 4.1** |
| Stomach | * | # | 10 | 6.4** | * | # | 3 | # |
| Colon excluding Rectum | 8 | 25.0** | 58 | 36.3 | 6 | 15.9** | 27 | 18.1 |
| Rectum and Rectosigmoid Junction | * | # | 25 | 15.8 | * | # | 4 | # |
| Liver | * | # | 9 | 5.4** | 5 | 16.4** | 10 | 6.4** |
| Pancreas | 7 | 21.0** | 22 | 14.2 | 6 | 17.6** | 22 | 14.1 |
| Lung and Bronchus | 28 | 88.0 | 144 | 90.6 | 26 | 84.5 | 125 | 80.4 |
| Melanoma of the Skin | 17 | 47.1** | 48 | 27.9 | * | # | 6 | 3.9** |
| Prostate | 41 | 120.7 | 174 | 106.8 | 7 | 30.5** | 29 | 23.5 |
| Urinary Bladder | 15 | 42.5** | 55 | 34.5 | * | # | 8 | 5.5** |
| Kidney and Renal Pelvis | 5 | 15.1** | 37 | 22.5 | * | # | 16 | 10.0** |
| Brain and Other Nervous System | * | # | 16 | 9.5** | * | # | 8 | 5.0** |
| Non-Hodgkin Lymphoma | 10 | 28.3** | 44 | 28.0 | 6 | 20.4** | 35 | 23.0 |
| Myeloma | * | # | 10 | 5.7** | * | # | 6 | 3.8** |
| Leukemia | * | # | 23 | 14.2 | * | # | 16 | 10.7** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 174 | 410.3 | 826 | 405.0 | 74 | 170.6 | 352 | 167.5 |
| Colon excluding Rectum | 11 | 25.2** | 48 | 22.6 | 8 | 18.3** | 29 | 13.8 |
| Rectum and Rectosigmoid Junction | 5 | 12.6** | 19 | 9.3** | * | # | 4 | # |
| Liver | * | # | 2 | # | * | # | 4 | # |
| Pancreas | 5 | 11.1** | 18 | 8.5** | * | # | 15 | 7.3** |
| Lung and Bronchus | 31 | 71.6 | 109 | 52.7 | 20 | 46.5 | 79 | 37.6 |
| Melanoma of the Skin | 10 | 25.5** | 45 | 23.7 | * | # | 4 | # |
| Breast | 37 | 87.0 | 257 | 125.1 | 15 | 35.3** | 58 | 27.5 |
| Cervix Uteri | * | # | 14 | 7.7** | * | # | 9 | 4.7** |
| Corpus Uteri | 6 | 14.5** | 53 | 26.1 | * | # | 2 | # |
| Ovary | 7 | 17.1** | 32 | 15.8 | * | # | 26 | 12.4 |
| Urinary Bladder | 6 | 14.1** | 19 | 9.0** | * | # | 6 | 2.7** |
| Kidney and Renal Pelvis | 8 | 18.1** | 23 | 11.2 | 6 | 13.1** | 10 | 4.5** |
| Brain and Other Nervous System | * | # | 10 | 5.1** | * | # | 11 | 5.2** |
| Non-Hodgkin Lymphoma | 8 | 17.9** | 31 | 14.9 | * | # | 15 | 7.1** |
| Myeloma | * | # | 9 | 4.2** | * | # | 8 | 3.9** |
| Leukemia | 6 | 14.0** | 18 | 8.9** | * | # | 13 | 6.2** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-2: Allen
Table 5-4: Benton
